#3: NewsBot: URGP Stock: Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
BURLINGAME, Calif., August 19 /PRNewswire-FirstCall/ -- Urigen
Pharmaceuticals,... |
September 1, 2008
12:31:52 PM |
#2: NewsBot: Urigen Announces Positive Phase II Clinical Trial Results with URG101
URG101 Significantly Reduces Painful Bladder Syndrome/Interstitial
... |
March 12, 2008
01:23:09 PM |
#1: NewsBot: Urigen Pharmaceuticals, Inc. Appoints Professor Christian Stief to Scientific Advisory Board
Urigen Pharmaceuticals, Inc. (OTCBB: URGP, http://www.urigen.com),
a... |
December 31, 2007
09:25:13 AM |
|
Tips for using stock message boards discussion forums
|
| 
| 
| 
| 
| 
| 
